Cargando…

Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN

One of the primary causes of blindness in the diabetic population is diabetic retinopathy (DR). Many people could have their sight saved if only DR were detected and treated in time. Numerous Deep Learning (DL)-based methods have been presented to improve human analysis. Using a DL model with three...

Descripción completa

Detalles Bibliográficos
Autores principales: Alwakid, Ghadah, Gouda, Walaa, Humayun, Mamoona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378524/
https://www.ncbi.nlm.nih.gov/pubmed/37510123
http://dx.doi.org/10.3390/diagnostics13142375
_version_ 1785079788340248576
author Alwakid, Ghadah
Gouda, Walaa
Humayun, Mamoona
author_facet Alwakid, Ghadah
Gouda, Walaa
Humayun, Mamoona
author_sort Alwakid, Ghadah
collection PubMed
description One of the primary causes of blindness in the diabetic population is diabetic retinopathy (DR). Many people could have their sight saved if only DR were detected and treated in time. Numerous Deep Learning (DL)-based methods have been presented to improve human analysis. Using a DL model with three scenarios, this research classified DR and its severity stages from fundus images using the “APTOS 2019 Blindness Detection” dataset. Following the adoption of the DL model, augmentation methods were implemented to generate a balanced dataset with consistent input parameters across all test scenarios. As a last step in the categorization process, the DenseNet-121 model was employed. Several methods, including Enhanced Super-resolution Generative Adversarial Networks (ESRGAN), Histogram Equalization (HIST), and Contrast Limited Adaptive HIST (CLAHE), have been used to enhance image quality in a variety of contexts. The suggested model detected the DR across all five APTOS 2019 grading process phases with the highest test accuracy of 98.36%, top-2 accuracy of 100%, and top-3 accuracy of 100%. Further evaluation criteria (precision, recall, and F1-score) for gauging the efficacy of the proposed model were established with the help of APTOS 2019. Furthermore, comparing CLAHE + ESRGAN against both state-of-the-art technology and other recommended methods, it was found that its use was more effective in DR classification.
format Online
Article
Text
id pubmed-10378524
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103785242023-07-29 Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN Alwakid, Ghadah Gouda, Walaa Humayun, Mamoona Diagnostics (Basel) Article One of the primary causes of blindness in the diabetic population is diabetic retinopathy (DR). Many people could have their sight saved if only DR were detected and treated in time. Numerous Deep Learning (DL)-based methods have been presented to improve human analysis. Using a DL model with three scenarios, this research classified DR and its severity stages from fundus images using the “APTOS 2019 Blindness Detection” dataset. Following the adoption of the DL model, augmentation methods were implemented to generate a balanced dataset with consistent input parameters across all test scenarios. As a last step in the categorization process, the DenseNet-121 model was employed. Several methods, including Enhanced Super-resolution Generative Adversarial Networks (ESRGAN), Histogram Equalization (HIST), and Contrast Limited Adaptive HIST (CLAHE), have been used to enhance image quality in a variety of contexts. The suggested model detected the DR across all five APTOS 2019 grading process phases with the highest test accuracy of 98.36%, top-2 accuracy of 100%, and top-3 accuracy of 100%. Further evaluation criteria (precision, recall, and F1-score) for gauging the efficacy of the proposed model were established with the help of APTOS 2019. Furthermore, comparing CLAHE + ESRGAN against both state-of-the-art technology and other recommended methods, it was found that its use was more effective in DR classification. MDPI 2023-07-14 /pmc/articles/PMC10378524/ /pubmed/37510123 http://dx.doi.org/10.3390/diagnostics13142375 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Alwakid, Ghadah
Gouda, Walaa
Humayun, Mamoona
Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title_full Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title_fullStr Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title_full_unstemmed Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title_short Enhancement of Diabetic Retinopathy Prognostication Using Deep Learning, CLAHE, and ESRGAN
title_sort enhancement of diabetic retinopathy prognostication using deep learning, clahe, and esrgan
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378524/
https://www.ncbi.nlm.nih.gov/pubmed/37510123
http://dx.doi.org/10.3390/diagnostics13142375
work_keys_str_mv AT alwakidghadah enhancementofdiabeticretinopathyprognosticationusingdeeplearningclaheandesrgan
AT goudawalaa enhancementofdiabeticretinopathyprognosticationusingdeeplearningclaheandesrgan
AT humayunmamoona enhancementofdiabeticretinopathyprognosticationusingdeeplearningclaheandesrgan